Food allergies and hypersensitivity: a review of pharmacotherapy and therapeutic strategies

被引:2
作者
Burks, Wesley [1 ]
Kulis, Mike [1 ]
Pons, Laurent [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
关键词
allergy immunotherapy; anaphylaxis; food allergy; peanut allergy;
D O I
10.1517/14656560802066409
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Food allergy is a major cause of life-threatening hypersensitivity reactions. Food-induced anaphylaxis is the most common reason for someone to present to the emergency department for an anaphylactic reaction. At present, the avoidance of the allergenic food is the only method of preventing further reactions for allergic patients. Objective: With better characterization of allergens and an understanding of the immunologic mechanism involved in this reaction, investigators have developed several therapeutic modalities potentially applicable to the treatment and eventual prevention of food allergy. This review identifies and discusses the potential treatment options for food allergy that are under development. Methods: Relevant articles are reviewed pertaining to the treatment of food allergy. Results/conclusion: Among the therapeutic options currently under investigation are anti-IgE therapy, peptide immunotherapy, traditional Chinese medicine, mutated protein immunotherapy, DNA immunization and immunization with immunostimulatory sequences linked to allergens. These novel forms of treatment for allergic disease hold promise for the safe and effective treatment of food-allergic individuals and the prevention of food allergy in the future.
引用
收藏
页码:1145 / 1152
页数:8
相关论文
共 49 条
  • [1] Asero R, 1998, CLIN EXP ALLERGY, V28, P1368, DOI 10.1046/j.1365-2222.1998.00399.x
  • [2] Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy
    Asero, R
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 84 (04) : 460 - 462
  • [3] How long does the effect of birch pollen injection SIT on apple allergy last?
    Asero, R
    [J]. ALLERGY, 2003, 58 (05) : 435 - 438
  • [4] Bohle B, 1999, EUR J IMMUNOL, V29, P2344, DOI 10.1002/(SICI)1521-4141(199907)29:07<2344::AID-IMMU2344>3.0.CO
  • [5] 2-R
  • [6] PERIPHERAL T-CELL TOLERANCE INDUCED IN NAIVE AND PRIMED MICE BY SUBCUTANEOUS INJECTION OF PEPTIDES FROM THE MAJOR CAT ALLERGEN FEL-D-I
    BRINER, TJ
    KUO, MC
    KEATING, KM
    ROGERS, BL
    GREENSTEIN, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) : 7608 - 7612
  • [7] Egg oral immunotherapy in nonanaphylactic children with egg allergy
    Buchanan, Ariana D.
    Green, Todd D.
    Jones, Stacie M.
    Scurlock, Amy M.
    Christie, Lynn
    Althage, Karen A.
    Steele, Pamela H.
    Pons, Laurent
    Heim, Rick M.
    Lee, Laurie A.
    Burks, A. Wesley
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : 199 - 205
  • [8] BURKS AW, 2003, ALLERGY, V67, P121
  • [9] New approaches for treatment of peanut allergy
    Burks, W
    Lehrer, SB
    Bannon, GA
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2004, 27 (03) : 191 - 196
  • [10] CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
    Chu, RS
    Targoni, OS
    Krieg, AM
    Lehmann, PV
    Harding, CV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) : 1623 - 1631